Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Ensysce Biosciences (ENSC) over the last 1 years, with Jun 2025 value amounting to $1,033.

  • Ensysce Biosciences' Total Non-Current Liabilities fell 89.26% to $1,033 in Q2 2025 from the same period last year, while for Jun 2025 it was $1,033, marking a year-over-year decrease of 89.26%. This contributed to the annual value of $10,096 for FY2024, which is 61.74% down from last year.
  • As of Q2 2025, Ensysce Biosciences' Total Non-Current Liabilities stood at $1,033, which was down 99.21% from $130,180 recorded in Q1 2025.
  • Over the past 5 years, Ensysce Biosciences' Total Non-Current Liabilities peaked at $8.4 million during Q2 2022, and registered a low of $1,033 during Q2 2025.
  • Over the past 3 years, Ensysce Biosciences' median Total Non-Current Liabilities value was $20,044 (recorded in 2023), while the average stood at $44,305.
  • Data for Ensysce Biosciences' Total Non-Current Liabilities shows a maximum YoY tumbled of 98.91% (in 2023) over the last 5 years.
  • Ensysce Biosciences' Total Non-Current Liabilities (Quarterly) stood at $3.1 million in 2021, then decreased by 8.78% to $2.8 million in 2022, then plummeted by 98.91% to $30,473 in 2023, then tumbled by 89.46% to $3,213 in 2024, then crashed by 89.26% to $1,033 in 2025.
  • Its last three reported values are $1,033 in Q2 2025, $130,180 for Q1 2025, and $3,213 during Q3 2024.